Coronary artery calcium testing: A call for universal coverage.
Cardiovascular disease (CVD), Atherosclerotic cardiovascular disease (ASCVD)
Coronary artery calcium (CAC), Atherosclerosis, Vulnerable patient, Computed tomography (CT) scan
Journal
Preventive medicine reports
ISSN: 2211-3355
Titre abrégé: Prev Med Rep
Pays: United States
ID NLM: 101643766
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
received:
14
12
2018
revised:
01
04
2019
accepted:
22
04
2019
entrez:
14
6
2019
pubmed:
14
6
2019
medline:
14
6
2019
Statut:
epublish
Résumé
Heart attacks kill more Americans than all cancers combined. Fatal heart attack victims have no symptoms until minutes before they die, hence early detection of high-risk asymptomatic individuals is needed. Even though heart attacks kill and cost more than cancers, as a nation we spend over 20 times more on screening for asymptomatic cancer than for asymptomatic atherosclerotic cardiovascular disease (ASCVD), the underlying cause of heart attacks. Currently, payers only cover screening for risk factors of ASCVD such as blood pressure and blood cholesterol. This approach tends to miss high-risk and over-treat low-risk individuals. Although treadmill stress testing with ECG is not indicated for ASCVD detection in asymptomatic individuals, it is done often, and frequently leads to misleading conclusions or unnecessary downstream diagnostic procedures. For example, former President Clinton had passed his treadmill stress tests for several years during his presidential annual checkup but had a heart attack shortly after his presidency. This common practice is a waste of our limited resources. Instead, a more accurate risk assessment using coronary artery calcium (CAC) testing is available; and has just been adopted by ACC/AHA guidelines, however payers do not cover it. CAC is measured non-invasively with a 5-minute CT-scan of the heart, and costs less than $200, whereas cancer screening with colonoscopy and mammography costs over $3000. There is an opportunity to save lives and dollars if CAC testing is covered for appropriately selected individuals. Texas has already passed HB1290 to mandate CAC coverage. Other states must step up and take actions.
Identifiants
pubmed: 31193256
doi: 10.1016/j.pmedr.2019.100879
pii: S2211-3355(19)30059-2
pii: 100879
pmc: PMC6525277
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100879Commentaires et corrections
Type : ErratumIn
Références
Am J Public Health Nations Health. 1959 Oct;49:1349-56
pubmed: 13814552
Circulation. 2003 Oct 7;108(14):1664-72
pubmed: 14530185
Circulation. 2003 Oct 14;108(15):1772-8
pubmed: 14557340
Am J Cardiol. 2006 Jul 17;98(2A):2H-15H
pubmed: 16843744
J Am Coll Cardiol. 2007 Jan 23;49(3):378-402
pubmed: 17239724
J Am Coll Cardiol. 2007 May 8;49(18):1860-70
pubmed: 17481445
Am Heart J. 2009 Jan;157(1):111-117.e2
pubmed: 19081406
JACC Cardiovasc Imaging. 2009 Jun;2(6):675-88
pubmed: 19520336
J Am Coll Cardiol. 2010 Mar 16;55(11):1110-7
pubmed: 20223365
Circulation. 2011 Mar 1;123(8):933-44
pubmed: 21262990
J Am Coll Cardiol. 2011 Apr 12;57(15):1622-32
pubmed: 21439754
Circulation. 1990 Sep;82(3 Suppl):II38-46
pubmed: 2203563
JAMA. 2012 Aug 22;308(8):788-95
pubmed: 22910756
Circulation. 2014 Jun 24;129(25 Suppl 2):S49-73
pubmed: 24222018
Eur Heart J. 2014 Oct 21;35(40):2792-6
pubmed: 25112665
JACC Cardiovasc Imaging. 2015 Aug;8(8):900-9
pubmed: 26189116
Am J Cardiol. 1989 Mar 7;63(10):114E-120E
pubmed: 2646888
Circulation. 2016 Jan 26;133(4):e38-360
pubmed: 26673558
Circulation. 2016 Mar 1;133(9):849-58
pubmed: 26801055
Circulation. 2016 Mar 22;133(12):1171-80
pubmed: 27002081
Circulation. 2017 Mar 7;135(10):e146-e603
pubmed: 28122885
JACC Cardiovasc Imaging. 2017 Aug;10(8):843-844
pubmed: 28797403
Scand J Med Sci Sports. 2018 Apr;28(4):1397-1403
pubmed: 29239051
J Am Coll Cardiol. 2018 Mar 13;71(10):1078-1089
pubmed: 29519347
Front Cardiovasc Med. 2018 Apr 06;5:36
pubmed: 29682509
J Am Coll Cardiol. 2018 Jul 24;72(4):434-447
pubmed: 30025580
J Am Coll Cardiol. 1985 Jun;5(6 Suppl):175B-184B
pubmed: 3889109
Lancet. 1996 May 25;347(9013):1447-51
pubmed: 8676628